R Ruiz M D a Professional Corporation
R Ruiz M D a Professional Corporation was paid $623K by Medicaid between Dec 2018 and Nov 2024, across 80 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoR RUIZ M D A PROFESSIONAL CORPORATION
MONTEBELLO, CA 90640
MONTEBELLO, CA 90640
33aNPI1245261023assigned 07/06/2006
33bProvider typeSpecialist
28Total paid$623K
24GClaims86,070
24DCodes billed80
24AFirst – last monthDec 2018 – Nov 2024
Compared with peers
Next to other Specialist providers in California
Rank by total paid#248 of 1,230
Median peer was paid$51K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28 | $130.00 | |
| 2019 | 7,879 | $42K | |
| 2020 | 10,145 | $53K | |
| 2021 | 15,237 | $119K | |
| 2022 | 18,583 | $137K | |
| 2023 | 18,668 | $138K | |
| 2024incomplete | 15,530 | $134K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 18,353 | 16,035 | $244K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 8,490 | 7,532 | $175K |
| G9920 | Screening performed and negative | 4.7% | 2,911 | 2,881 | $29K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.0% | 3,479 | 3,055 | $25K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.8% | 2,988 | 2,821 | $24K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.9% | 373 | 372 | $12K |
| 99000 | 1.6% | 4,735 | 4,316 | $10K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 1.5% | 1,399 | 1,383 | $10K |
| 97803 | 1.5% | 2,894 | 2,886 | $9K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 1.4% | 1,481 | 1,373 | $9K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.0% | 708 | 705 | $6K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.0% | 786 | 785 | $6K |
68 more codes
| 97802 | <1% | 1,764 | $6K | |
| 90686 | <1% | 921 | $6K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,186 | $6K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,803 | $5K |
| 99385 | <1% | 74 | $5K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 177 | $5K |
| 92551 | <1% | 1,348 | $4K | |
| 0003A | <1% | 57 | $2K | |
| 0072A | <1% | 54 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 156 | $2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 485 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,571 | $2K |
| 0001A | <1% | 44 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 971 | $2K |
| 90674 | <1% | 141 | $1K | |
| 0071A | <1% | 38 | $1K | |
| 90688 | <1% | 174 | $1K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 100 | $1K |
| 99383 | <1% | 12 | $1K | |
| 0002A | <1% | 28 | $1K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 751 | $1K |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 68 | $998.08 |
| 90658 | <1% | 65 | $791.36 | |
| 99406 | <1% | 395 | $780.71 | |
| 93000 | <1% | 79 | $732.23 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,365 | $645.23 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 29 | $583.23 |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | <1% | 295 | $395.10 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 71 | $369.44 |
| H0049 | Alcohol and/or drug screening | <1% | 1,943 | $307.04 |
| 81025 | <1% | 115 | $261.37 | |
| 88150 | <1% | 43 | $254.14 | |
| 90651 | <1% | 55 | $197.91 | |
| 1220F | <1% | 98 | $180.00 | |
| 99173 | <1% | 1,079 | $168.93 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 17 | $130.18 |
| 1125F | <1% | 165 | $85.56 | |
| 90734 | <1% | 14 | $81.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 37 | $71.85 |
| 3008F | <1% | 7,251 | $66.90 | |
| 90715 | <1% | 12 | $45.00 | |
| 81003 | <1% | 223 | $34.87 | |
| 1036F | <1% | 2,339 | $30.00 | |
| 90656 | <1% | 17 | $23.99 | |
| 88142 | <1% | 30 | $18.13 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 57 | $18.00 |
| 3078F | <1% | 2,142 | $13.00 | |
| 94760 | <1% | 63 | $11.06 | |
| 90657 | <1% | 20 | $10.38 | |
| 3074F | <1% | 1,783 | $8.20 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 192 | $7.71 |
| 3077F | <1% | 122 | $6.00 | |
| 3079F | <1% | 46 | $2.70 | |
| 3353F | <1% | 100 | $2.10 | |
| 3351F | <1% | 544 | $1.20 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 93 | $0.00 |
| 1160F | 0% | 69 | $0.00 | |
| 1159F | 0% | 69 | $0.00 | |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 0% | 128 | $0.00 |
| 90461 | 0% | 15 | $0.00 | |
| 3046F | 0% | 27 | $0.00 | |
| 99446 | 0% | 32 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 13 | $0.00 |
| 99496 | 0% | 43 | $0.00 | |
| 99447 | 0% | 108 | $0.00 | |
| 1000F | 0% | 85 | $0.00 | |
| 1111F | 0% | 24 | $0.00 | |
| 3075F | 0% | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUIZ, RUBEN (CEO/PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| R Ruiz M D a Medical Corp | Rialto, CA | $1.80M |
| Ruben Ruiz M D a Medical Corporation | Ontario, CA | $1.59M |
| Ruben M Ruiz III MD INC | Rosemead, CA | $50K |
| Ruben Ruiz MD a Medical Corporation | Ontario, CA | $30K |
| Ruben M Ruiz III Medical Center | Rosemead, CA | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.